Cargando…
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
BACKGROUND: Thrombotic disease complicates severe SARS‐CoV‐2 infection and is associated with increased morbidity and mortality. Various anticoagulation strategies have been evaluated in hospitalized patients to prevent complications. The impact of chronic anticoagulation before SARS‐CoV‐2 infection...
Autores principales: | Lachant, Daniel J., Lachant, Neil A., Kouides, Peter, Rappaport, Stephen, Prasad, Paritosh, White, R James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770966/ https://www.ncbi.nlm.nih.gov/pubmed/33448631 http://dx.doi.org/10.1111/jth.15032 |
Ejemplares similares
-
Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza()
por: Lachant, Daniel, et al.
Publicado: (2021) -
Legionella micdadei: A Forgotten Etiology of Growing Cavitary Nodules: A Case Report and Literature Review
por: Lachant, Daniel, et al.
Publicado: (2015) -
Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
por: Lachant, Daniel J., et al.
Publicado: (2021) -
Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
por: Lachant, Daniel, et al.
Publicado: (2022) -
Comparison of chest- and wrist-based actigraphy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2021)